Abstract:ImportanceThyroid cancer is more common in women than in men, but the associated causes of these differences are not fully understood.ObjectiveTo compare sex-specific thyroid cancer rates in the US to the prevalence of subclinical thyroid cancer at autopsy.Data SourcesData on thyroid cancer incidence and mortality by sex among US adults (≥18 years) were extracted from the National Cancer Institute's Surveillance, Epidemiology, and End Results Program (SEER) data for 1975 to 2017. Embase, PubMed, and Web of Science databases were searched for studies on the prevalence of subclinical thyroid cancer at autopsy of men and women, from inception to May 31, 2021.Study SelectionThe Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guideline was used to perform a systematic search for articles reporting the prevalence of subclinical thyroid cancer in autopsy results of both women and men. Of 101 studies identified, 8 studies containing 12 data sets met inclusion criteria; ie, they examined the whole thyroid gland, stated the number of thyroids examined, and reported results by sex. Excluded studies reported thyroid cancer in Japan after the atomic bombs or Chernobyl after the nuclear disaster; did not examine the whole thyroid gland or had incomplete information on thyroid examination methods; or did not report rates by sex.Data Extraction and SynthesisThyroid cancer incidence and mortality data by sex, histologic type, and tumor size were extracted from SEER. The inverse variance heterogeneity model was used to meta-analyze the prevalence and the odds ratio of subclinical thyroid cancer by sex from 8 studies (12 data sets) on thyroid cancer prevalence in autopsy results.Main Outcomes and MeasuresIncidence and mortality of thyroid cancer, by histologic type and tumor size; prevalence of thyroid cancer in autopsy results.ResultsIn 2017, 90% of thyroid cancers diagnosed were papillary thyroid cancer (PTC) and in 2013 to 2017, the women to men incidence ratio for small (≤2 cm) PTC was 4.39:1. The incidence ratio approached 1:1 as cancer type lethality increased. The ratio of thyroid cancer mortality by gender was 1.02:1 and remained stable from 1992 to 2017. Results of the meta-analysis showed that the pooled autopsy prevalence of subclinical PTC was 14% in women (95% CI, 8%-20%) and 11% in men (95% CI, 5%-18%). The pooled odds ratio of subclinical PTC in women compared with men was 1.07 (95% CI, 0.80-1.42).Conclusions and RelevanceThis cohort study and meta-analysis found that the belief that women get thyroid cancer more often than men is an oversimplification. The gender disparity is mostly confined to the detection of small subclinical PTCs, which are equally common in both sexes at autopsy but identified during life much more often in women than men. As the lethality of the cancer type increases, the ratio of detection by gender approaches 1:1. This phenomenon may be associated with gender differences in health care utilization and patterns of clinical thinking and can harm both women, who are subject to overdetection, and men, who may be at risk of underdetection.

Benign Thyroid Diseases: Are There Gender-Specific Differences for Diagnosis and Treatment of Nontoxic Thyroid Nodules? Results from a 4-Year Retrospective Analysis of an Endocrine Tumor Board

Evaluation of Gender Inequity in Thyroid Cancer Diagnosis

Diagnosing and management of thyroid nodules and goiter - current perspectives

Sexual dimorphism in medullary thyroid cancer aggressiveness

Evaluation of clinical and biohumoral characteristics and morphological findings of thyroid gland in patients with atoxic nodular and multinodular goiter

The common pathogenesis of nodular goiter in both sexes: An exploration into gene expression and signaling pathways

Thyroid nodules: Α guide to assessment, treatment and follow-up

Differences in surgical outcomes between cervical goiter and retrosternal goiter: an international, multicentric evaluation

Thyroid nodules: diagnosis and management

Surgical management of anterior mediastinal tumors of thyroid origin: a comprehensive analysis of approaches, techniques, and outcomes

Comparative Study between Total Thyroidectomy and Hemithyroidectomy in Treatment of Solitary Thyroid Nodules Diagnosed as Follicular Lesions by Fine-Needle Aspiration Cytology

Prevalence of Thyroid Nodule in Unselected Populations

Evaluation of Ultrasonographic Characteristics and Cytopathological Results of Autonomous (Toxic) Thyroid Nodules

Applicability of the "Taller than Wide" Criterium in Primary/Secondary Care Units and the Role of Thyroid Scintigraphy

Is hemithyroidectomy a rational management for benign nodular goitre? A Multicentre Retrospective Single Group Study

The Incidence of Thyroid Cancer in Bethesda III Thyroid Nodules: A Retrospective Analysis at a Single Endocrine Surgery Center

An Epidemiological Study of Risk Factors of Thyroid Nodule and Goiter in Chinese Women

Assessment of possible malignancy of the thyroid nodules based on clinical manifestations and pre-operative examinations.

Gender-Specific Risk of Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.

A Clinical Analysis of Thyroid Carcinoma in Young Females

New insights into the diagnosis of nodular goiter